Salvage Treatment After rInterferon Α-2a in Advanced Neuroendocrine Tumors

Acta Oncologica - United Kingdom
doi 10.3109/02841869309083920
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Current Treatment Strategies for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Treatment Patterns of Gastrointestinal Neuroendocrine Tumors (NET).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

Sunitinib in Advanced Pancreatic Neuroendocrine Tumors: Latest Evidence and Clinical Potential

Therapeutic Advances in Medical Oncology
Oncology
2011English

Outcomes After Surgery for Malignant Pancreatic Neuroendocrine Tumors

Kurdistan Journal of Applied Research
2019English

Outcomes After Surgery for Malignant Pancreatic Neuroendocrine Tumors

Kurdistan Journal of Applied Research
2019English

Resistance to Targeted Treatment of Gastroenteropancreatic Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Medical Treatment of Neuroendocrine Gut and Pancreatic Tumors

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Role of Somatostatin Analogues in the Treatment of Neuroendocrine Tumors

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy